openPR Logo
Press release

Asia-Pacific Autoimmune Disease Diagnostics Market Top Leaders: F. HOFFMANN-LA ROCHE, SIEMENS HEALTHINEERS, NOVARTIS AG, THERMO FISHER SCIENTIFIC, MYRIAD GENETICS, ABBOTT LABORATORIES and BIO-RAD LABORATORIES

09-26-2018 06:06 PM CET | Health & Medicine

Press release from: Market Prognosis

Asia-Pacific Autoimmune Disease Diagnostics Market Highlights
The Asia-pacific autoimmune disease diagnostics market is expected to register a CAGR of around 8% during the forecast period, 2018 to 2023. Autoimmune diseases are a group of diseases characterized by inflammatory reactions caused by immune responses mistakenly generated against body tissues. The term autoimmune disease refers to a varied group of illnesses that involve almost every human organ system. Environmental, infectious, and genetic factors play an important role in initiating or exacerbating autoimmune diseases.

Get your sample report now @ https://marketprognosis.com/sample-request/16892
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Japan Lead the Market in Asia-pacific Region
The Japan autoimmune disease diagnostics market holds the largest market share in 2017 in Europe region with a CAGR of over 7.5% due to the presence of large number of population with autoimmune condition as of 2017 in Japan. Rheumatoid arthritis is the most prevalent autoimmune condition in the country.

Key Developments in the Market:
August 2017 u2013 Thermo Fisher Scientific has acquired the Patheon, a leading contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotechnology sectors

Major players:
F. HOFFMANN-LA ROCHE, SIEMENS HEALTHINEERS INC, NOVARTIS AG, THERMO FISHER SCIENTIFIC, MYRIAD GENETICS, ABBOTT LABORATORIES and BIO-RAD LABORATORIES, among others.

Get Discount on this report @ https://marketprognosis.com/discount-request/16892
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Partnerships with Physicians and Clinical Laboratories
Treatment of autoimmune diseases requires diagnosis of the disease at the onset of disease or later. This involves clinical laboratories checking for symptoms and providing the information to physician for better treatment of the disease. All the diagnostic laboratories do not have proper equipment for carrying out immunoassays. In that case, patient will face trouble in getting the tests done and then handing over the result to the physician. To overcome these problems, recently physicians and clinical laboratories started collaborating. Since, a physician knows where proper immunoassays and immunodiagnostics can be carried out, physician collaborates with that laboratory and suggests patient to get their tests done from there and the results will directly be sent to the physician. And, with increasing usage of Electronic Medical Records (EMR), labs have access to real-time test data and metrics extracted from the Laboratory Information System (LIS) and physicians too have access to these records, which increases efficiency in diagnosis, thus boosting autoimmune diagnosticsmarket. The other factors such as improved laboratory automation, growing public awareness of autoimmune disease, technological advancements and expansion in coverage allowed by patient protection and affordable care act are driving the Asia-pacific autoimmune disease diagnostics market.

Slow Turnaround Time for Autoimmune Disease Diagnostic Test Results
Diagnosis of autoimmune diseases is a time consuming process. It involves procedures, such as serum testing for diseases, like rheumatoid arthritis, Addison’s disease, Hashimoto’s disease, and others. Testing protocols allow autoimmune disorders to be diagnosed in a highly efficient, cost effective manner. However, turnaround time for the test results is slow, owing to lesser automation techniques. It takes days to deliver all test results to the patients with proper explanation of false positive results. For example Auto-immune Lymph proliferative Syndrome is an autoimmune disease with turnaround time of up to 12 weeks; single gene sequencing takes 4 weeks. Therefore, this slow turnaround time is hindering the Asia-pacific autoimmune disease diagnostics market. The other factor, such as high frequency of false positive result is also hindering the growth of the market.

For More Information, Please Visit @ https://marketprognosis.com/enquiry/16892
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia-Pacific Autoimmune Disease Diagnostics Market Top Leaders: F. HOFFMANN-LA ROCHE, SIEMENS HEALTHINEERS, NOVARTIS AG, THERMO FISHER SCIENTIFIC, MYRIAD GENETICS, ABBOTT LABORATORIES and BIO-RAD LABORATORIES here

News-ID: 1265212 • Views:

More Releases from Market Prognosis

Third-Party Logistics (3PL) Market Latest Study Focuses On Current, Future Innovations and Foreseen Till 2026 | FedEx, Exel Logistics, Menlo Worldwide Logistics, Ryder Logistics
Third-Party Logistics (3PL) Market Latest Study Focuses On Current, Future Innov …
The report covers a forecast and an analysis of the Third-Party Logistics (3PL) Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Third-Party Logistics (3PL) Market: The report spread across 90 pages is an overview of the Global Third-Party Logistics (3PL) Market. These report study based on the Third-Party
Ride-Hailing Market: An Insight on the Important Factors and Trends Influencing by Top Key Players (Didi, Uber, Lyft, Gett, Hailo, Ola Cabs, Cabify, GoCatch) | Foreseen Till 2026
Ride-Hailing Market: An Insight on the Important Factors and Trends Influencing …
The report covers a forecast and an analysis of the Ride-Hailing Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Ride-Hailing Market: The report spread across 90 pages is an overview of the Global Ride-Hailing Market. These report study based on the Ride-Hailing Market. It is a complete overview
COVID-19 Impact on Professional Indemnity Insurance Market 2021-2026: Industry Insight and Growth Strategy by Business Players - AIG, Chubb (ACE), Allianz, XL Group, AXA, Aviva
COVID-19 Impact on Professional Indemnity Insurance Market 2021-2026: Industry I …
The report covers a forecast and an analysis of the Professional Indemnity Insurance Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Professional Indemnity Insurance Market: The report spread across 90 pages is an overview of the Global Professional Indemnity Insurance Market. These report study based on the Professional
Modular Construction Market Future Growth Explored in Latest Research Report by 2026 | Komatsu, Kiewit, Skanska, L&T, Taisei, ACS Group, Bouygues Construction
Modular Construction Market Future Growth Explored in Latest Research Report by …
The report covers a forecast and an analysis of the Modular Construction Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Modular Construction Market: The report spread across 90 pages is an overview of the Global Modular Construction Market. These report study based on the Modular Construction Market. It

All 5 Releases


More Releases for Autoimmune

Autoimmune Disease Diagnostics Market - Forecast to 2026
The findings reviewed by GME stated that the Global Autoimmune Disease Diagnostics Market would grow at a CAGR value of 8.9 percent from 2021 to 2026. Today, the advancing technology & automation, increasing awareness about risks and implications of autoimmune disease if left undiagnosed & untreated, and the awareness about the benefits of various diagnostics available are accelerating growth in the market. Also, there has been an exponential increase
The Autoimmune Registry releases first complete list of autoimmune diseases with …
The Autoimmune Registry Inc (ARI) has published its first comprehensive List of Autoimmune Diseases: https://www.autoimmuneregistry.org/autoimmune-diseases. It includes over 150 diseases, 40 subtypes, and 60 synonyms. ARI created the list to provide patients and researchers easy access to the latest literature and information about autoimmune disease. ARI’s list is searchable and filterable, with links to peer-reviewed research, patient groups, and other resources. Between 15 and 30 million people in
Autoimmune Disease Diagnostics Market: Growing Awareness among People about Auto …
According to the recent report by Transparency Market Research, the global autoimmune disease diagnostics market has a highly consolidated scenario. The market is dominated by a handful of players. However, these players have a stronghold over the dynamics of market and pose a great challenge for any new entrant to set its foot in the market. Read Report Overview - https://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html To reduce effects of such hindrances, the new entrants are
Autoimmune Disease Therapeutics Market Boost due to increase in incidence of aut …
According to a new report published by Allied Market Research, titled,"Autoimmune Disease Therapeutics Market by Drug Class, Indication, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025," the global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is expected to reach $153,320 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025. Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5185?utm_source=openpr&utm_medium=Niranjan Autoimmune disease therapeutics include
Autoimmune Treatment Market North America Leads the Global Autoimmune Treatment …
The global autoimmune treatment market is growing significantly due to increasing incidences of autoimmune diseases, up surging healthcare expenditure, and advancements in the technologies for the development of autoimmune diseases therapeutics. Autoimmune diseases are chronic in nature and do not have permanent treatment. This creates ample growth opportunity for the autoimmune treatment market, to grow at a considerable rate in the coming years. The advanced research and development facilities, and
Autoimmune Disease Diagnostics Market: Rise in Autoimmune Diseases, alongside Gr …
Global Autoimmune Disease Diagnostics Market: Snapshot The global autoimmune disease diagnostics market is expected to witness a modest growth in the coming years on account of the growing incidences of autoimmune diseases among people worldwide. Efficient autoimmune disease diagnostics has become absolutely essential to tackle this issue. Governments across nations are also increasing their spending towards healthcare in light of these growing incidences of autoimmune diseases. This has also resulted in